• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 2009 年 pH1N1 流感 A 中,使用治疗性血浆置换作为抢救疗法——与呼吸衰竭和血流动力学休克相关。

Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock.

机构信息

Critical Care Medicine Division, Department of Pediatrics and Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

出版信息

Pediatr Crit Care Med. 2011 Mar;12(2):e87-9. doi: 10.1097/PCC.0b013e3181e2a569.

DOI:10.1097/PCC.0b013e3181e2a569
PMID:20453703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6328374/
Abstract

OBJECTIVE

Acute pneumonitis with acute lung injury is a cause of significant mortality related to the 2009 pH1N1 influenza A virus. Widespread lung inflammation and increased pulmonary vascular permeability has been noted on autopsy. Also, many of these patients present with significant hemodynamic compromise suggesting systemic cytokine release. Therefore, attenuating circulating cytokines, and other mediators, by blood purification techniques is a theoretically attractive strategy. We report the use therapeutic plasma exchange in three children with 2009 H1N1 related acute lung injury with severe hemodynamic compromise that had failed conventional therapeutic interventions.

DESIGN

Case series.

SETTING

Pediatric intensive care unit in a university children's hospital.

PATIENTS

Three children, aged 8, 11, and 17 yrs, with acute respiratory distress syndrome and hemodynamic compromise related to the 2009 pH1N1 influenza A virus documented by polymerase chair reaction. All patients were on mechanical ventilation and inhaled nitric oxide, and one patient was on extracorporeal membrane oxygenation. Therapeutic plasma exchange was used as a rescue strategy.

INTERVENTIONS

Each patient received three exchanges of 35-40 mL/kg on consecutive days.

MEASUREMENTS

All three patients had dramatic reduction in pediatric logistic organ dysfunction scores, oxygen requirements, and vasopressor requirements after two exchanges. All survived with good functional recovery.

MAIN RESULTS

In this small series of patients with H1N1/acute respiratory distress syndrome and hemodynamic compromise, therapeutic plasma exchange appeared to benefit as a method of mitigating the associated cytokine storm. The procedure was well tolerated with no reported side effects. All three patients survived, defying the predicted mortality. Because these procedures used the filtration exchange method, it was performed in a timely fashion by intensive care unit personnel and on equipment already available in the intensive care unit for renal support.

CONCLUSIONS

This very limited case series suggest there may be a role for therapeutic plasma exchange as a rescue therapy in severe shock and acute lung injury related to pH1N1 that has not responded to traditional therapy.

摘要

目的

急性肺炎伴急性肺损伤是与 2009 年 pH1N1 甲型流感病毒相关的高死亡率原因。尸检发现肺部广泛炎症和肺血管通透性增加。此外,许多此类患者表现出明显的血流动力学障碍,表明全身细胞因子释放。因此,通过血液净化技术减轻循环细胞因子和其他介质是一种具有吸引力的理论策略。我们报告了三例 2009 年 H1N1 相关急性肺损伤伴有严重血流动力学障碍的儿童使用治疗性血浆置换的情况,这些儿童对常规治疗干预无效。

设计

病例系列。

地点

大学儿童医院的儿科重症监护病房。

患者

3 例年龄分别为 8、11 和 17 岁的儿童,其急性呼吸窘迫综合征和血流动力学障碍与聚合酶链反应证实的 2009 年 pH1N1 甲型流感病毒有关。所有患者均接受机械通气和吸入性一氧化氮治疗,1 例患者接受体外膜氧合治疗。治疗性血浆置换被用作挽救策略。

干预措施

每位患者连续 3 天接受 35-40ml/kg 的 3 次交换。

测量

两次交换后,所有 3 名患者的儿科逻辑器官功能障碍评分、氧需求和血管加压素需求均明显降低。所有患者均存活且功能恢复良好。

主要结果

在这组患有 H1N1/急性呼吸窘迫综合征和血流动力学障碍的患者中,治疗性血浆置换似乎是一种减轻相关细胞因子风暴的方法。该程序耐受性良好,无不良反应报告。所有患者均存活,这与预测的死亡率相悖。由于这些程序使用过滤交换方法,因此可以由重症监护病房的工作人员在重症监护病房中已经可用的设备上及时进行。

结论

这项非常有限的病例系列研究表明,在对传统治疗无反应的 pH1N1 相关严重休克和急性肺损伤中,治疗性血浆置换可能作为一种挽救性治疗方法发挥作用。

相似文献

1
Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock.在 2009 年 pH1N1 流感 A 中,使用治疗性血浆置换作为抢救疗法——与呼吸衰竭和血流动力学休克相关。
Pediatr Crit Care Med. 2011 Mar;12(2):e87-9. doi: 10.1097/PCC.0b013e3181e2a569.
2
Fulminant pH1N1-09 influenza-associated myocarditis in pediatric patients.儿童患者中暴发性 pH1N1-09 流感相关性心肌炎。
Pediatr Crit Care Med. 2011 Mar;12(2):e99-e101. doi: 10.1097/PCC.0b013e3181e28887.
3
Rescue therapy in adult and pediatric patients with pH1N1 influenza infection: a tertiary center intensive care unit experience from April to October 2009.2009 年 4 月至 10 月,三级中心重症监护病房成人和儿童 pH1N1 流感感染患者的抢救治疗:一项经验回顾。
Crit Care Med. 2010 Nov;38(11):2103-7. doi: 10.1097/CCM.0b013e3181f268f1.
4
Influenza A (pH1N1) infection in children admitted to a pediatric intensive care unit: differences with other respiratory viruses.儿童甲型流感(pH1N1)感染:与其他呼吸道病毒的区别。
Pediatr Crit Care Med. 2011 May;12(3):e136-40. doi: 10.1097/PCC.0b013e3181e28862.
5
Critically ill patients with 2009 influenza A(H1N1) infection in Canada.加拿大2009年甲型H1N1流感感染的重症患者。
JAMA. 2009 Nov 4;302(17):1872-9. doi: 10.1001/jama.2009.1496. Epub 2009 Oct 12.
6
Extracorporeal membrane oxygenation in acute respiratory distress syndrome due to influenza A (H1N1)pdm09 pneumonia. A single-center experience during the 2013-2014 season.甲型H1N1流感大流行病毒肺炎所致急性呼吸窘迫综合征的体外膜肺氧合治疗:2013 - 2014年季的单中心经验
Rev Bras Ter Intensiva. 2017 Jul-Sep;29(3):271-278. doi: 10.5935/0103-507X.20170048. Epub 2017 Sep 28.
7
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.体外膜肺氧合治疗2009年甲型H1N1流感所致急性呼吸窘迫综合征
JAMA. 2009 Nov 4;302(17):1888-95. doi: 10.1001/jama.2009.1535. Epub 2009 Oct 12.
8
Successful use of extracorporeal membrane oxygenation for pH1N1-induced refractory hypoxemia in a child with hypoplastic left heart syndrome.体外膜肺氧合成功治疗小儿左心发育不良伴 pH1N1 诱导难治性低氧血症
Pediatr Crit Care Med. 2011 Nov;12(6):e398-401. doi: 10.1097/PCC.0b013e3181fe3189.
9
[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].[西班牙重症与危重症医学及冠心病监护病房学会(SEMICYUC)传染病工作组(GTEI)以及西班牙传染病与临床微生物学会(SEIMC)危重症患者感染研究组(GEIPC)关于入住重症监护病房的重症成年甲型H1N1流感患者诊断和治疗的建议]
Med Intensiva. 2012 Mar;36(2):103-37. doi: 10.1016/j.medin.2011.11.020. Epub 2012 Jan 13.
10
Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A.体外膜肺氧合治疗 2009 年 H1N1 流感病毒导致的严重难治性呼吸衰竭
Respir Care. 2011 Jul;56(7):941-6. doi: 10.4187/respcare.01066. Epub 2011 Feb 21.

引用本文的文献

1
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations.病毒性脓毒症:诊断、临床特征、发病机制及临床考量
Mil Med Res. 2024 Dec 16;11(1):78. doi: 10.1186/s40779-024-00581-0.
2
Beyond conventional care: The therapeutic potential of hemoperfusion in severe COVID-19.超越传统治疗:血液灌流在重症 COVID-19 中的治疗潜力
World J Crit Care Med. 2024 Dec 9;13(4):97631. doi: 10.5492/wjccm.v13.i4.97631.
3
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis.

本文引用的文献

1
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy.急性呼吸窘迫综合征中全身炎症的激活与调节:延长糖皮质激素治疗的理论依据
Chest. 2009 Dec;136(6):1631-1643. doi: 10.1378/chest.08-2408. Epub 2009 Oct 3.
2
Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.墨西哥出现的源自猪的甲型H1N1流感所致肺炎及呼吸衰竭
N Engl J Med. 2009 Aug 13;361(7):680-9. doi: 10.1056/NEJMoa0904252. Epub 2009 Jun 29.
3
Differences in serum cytokine levels between influenza virus A and B infections in children.
MTx.100柱血浆吸附治疗重症COVID-19患者:一项前瞻性研究和倾向评分分析
J Intensive Care Med. 2025 Mar;40(3):314-319. doi: 10.1177/08850666241280031. Epub 2024 Sep 12.
4
[Therapeutic Options for the Management of Severe COVID-19: A Rheumatology Perspective].[重症新型冠状病毒肺炎治疗方案:风湿病学视角]
Reumatol Clin. 2021 Oct;17(8):431-436. doi: 10.1016/j.reuma.2020.05.002. Epub 2020 May 16.
5
Indications and Outcomes of Patients Receiving Therapeutic Plasma Exchange under Critical Care Conditions: A Retrospective Eleven-Year Single-Center Study at a Tertiary Care Center.重症监护条件下接受治疗性血浆置换患者的适应症及结局:一项在三级医疗中心进行的为期十一年的单中心回顾性研究
J Clin Med. 2023 Apr 14;12(8):2876. doi: 10.3390/jcm12082876.
6
Use of therapeutic plasma exchange in COVID-19: A systematic review of current evidence.在 COVID-19 中使用治疗性血浆置换:当前证据的系统评价。
Ther Apher Dial. 2022 Dec;26 Suppl 1(Suppl 1):3-11. doi: 10.1111/1744-9987.13779. Epub 2022 Dec 5.
7
Plasma exchange and COVID 19.血浆置换与新型冠状病毒肺炎
Transfus Apher Sci. 2022 Dec;61(6):103598. doi: 10.1016/j.transci.2022.103598. Epub 2022 Nov 12.
8
Acute Kidney Injury and Blood Purification Techniques in Severe COVID-19 Patients.重症 COVID-19 患者的急性肾损伤与血液净化技术
J Clin Med. 2022 Oct 25;11(21):6286. doi: 10.3390/jcm11216286.
9
Apheresis and COVID-19 in intensive care unit (ICU).血浆治疗与重症监护病房(ICU)中的 COVID-19。
Transfus Apher Sci. 2022 Dec;61(6):103593. doi: 10.1016/j.transci.2022.103593. Epub 2022 Nov 1.
10
Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.血浆置换对 COVID-19 患者死亡率的影响:系统评价和荟萃分析。
Int J Infect Dis. 2022 Sep;122:332-336. doi: 10.1016/j.ijid.2022.06.014. Epub 2022 Jun 14.
儿童甲型和乙型流感病毒感染之间血清细胞因子水平的差异。
Cytokine. 2009 Jul;47(1):65-8. doi: 10.1016/j.cyto.2009.05.003. Epub 2009 Jun 3.
4
Improvement of monocyte function and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis.高容量连续性静脉-静脉血液滤过对重症急性胰腺炎患者单核细胞功能及免疫稳态的改善作用
Int J Artif Organs. 2008 Oct;31(10):882-90. doi: 10.1177/039139880803101004.
5
Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.强化血浆置换可增加具有血小板反应蛋白基序的解聚素和金属蛋白酶13的活性,并逆转血小板减少症相关性多器官功能衰竭患儿的器官功能障碍。
Crit Care Med. 2008 Oct;36(10):2878-87. doi: 10.1097/ccm.0b013e318186aa49.
6
Effect of plasmapheresis on the immune system in endotoxin-induced sepsis.血浆置换对内毒素诱导的脓毒症免疫系统的影响。
Blood Purif. 2008;26(2):145-50. doi: 10.1159/000113507. Epub 2008 Jan 22.
7
Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury.脓毒症及脓毒症相关急性肾损伤的体外血液净化
Blood Purif. 2008;26(1):30-5. doi: 10.1159/000110560. Epub 2008 Jan 10.
8
Extracorporeal therapies in the treatment of sepsis: experience and promise.体外治疗在脓毒症治疗中的应用:经验与前景
Semin Pediatr Infect Dis. 2006 Apr;17(2):72-9. doi: 10.1053/j.spid.2006.04.005.
9
Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy.持续静静脉血液滤过可能会提高骨髓移植或化疗后急性呼吸窘迫综合征患者的生存率。
J Pediatr Hematol Oncol. 2003 Oct;25(10):801-5. doi: 10.1097/00043426-200310000-00012.
10
Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.血浆置换作为包括急性肾衰竭在内的多器官功能衰竭的挽救疗法。
Crit Care Med. 2003 Jun;31(6):1730-6. doi: 10.1097/01.CCM.0000064742.00981.14.